Jennifer Doudna from the University of California, Berkeley, writes at the Financial Times that though genome editing has the potential to treat a number of genetic diseases, it may first affect people's lives by being applied to agricultural issues. The FT has named CRISPR researcher Doudna one of its Masters of Science 2018.